Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (N/A)
Received: 18 September 2018
Accepted: 20 May 2019
First Online: 29 May 2019
Ethics approval and consent to participate
: Ethics approval was obtained from Quorum Review IRB under QR# 31726/1.<b>Ethical approval:</b> All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.<b>Informed consent:</b> Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Nina Galipeau, Brittany Klooster, and Meaghan Krohe were employees of Adelphi Values at the time this manuscript was written, which received payment from Novartis Pharmaceuticals to assist with manuscript preparation. Derek Tang was an employee of Novartis Pharmaceuticals. Dennis Revicki and David Cella were paid consultants to Novartis related to this project.